Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telemedicine | 4 | 2019 | 225 | 0.730 |
Why?
|
| Glaucoma, Neovascular | 1 | 2021 | 5 | 0.720 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2020 | 11 | 0.640 |
Why?
|
| Ophthalmology | 2 | 2017 | 46 | 0.600 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 135 | 0.590 |
Why?
|
| Pseudotumor Cerebri | 1 | 2017 | 12 | 0.510 |
Why?
|
| Remote Consultation | 1 | 2017 | 16 | 0.510 |
Why?
|
| Retina | 1 | 2017 | 215 | 0.440 |
Why?
|
| Delivery of Health Care | 3 | 2019 | 452 | 0.310 |
Why?
|
| Tomography, Optical Coherence | 3 | 2020 | 131 | 0.300 |
Why?
|
| Macular Degeneration | 2 | 2019 | 50 | 0.300 |
Why?
|
| Glaucoma | 2 | 2019 | 36 | 0.290 |
Why?
|
| Diabetic Retinopathy | 2 | 2019 | 82 | 0.290 |
Why?
|
| Cataract | 2 | 2019 | 87 | 0.290 |
Why?
|
| Bufanolides | 2 | 2018 | 5 | 0.260 |
Why?
|
| Visual Acuity | 3 | 2020 | 209 | 0.220 |
Why?
|
| Nerve Fibers | 2 | 2020 | 40 | 0.200 |
Why?
|
| Retinal Ganglion Cells | 2 | 2020 | 71 | 0.200 |
Why?
|
| Eye Burns | 1 | 2020 | 6 | 0.170 |
Why?
|
| Resistance Training | 1 | 2020 | 14 | 0.170 |
Why?
|
| Keratitis | 1 | 2020 | 12 | 0.170 |
Why?
|
| Wet Macular Degeneration | 1 | 2020 | 22 | 0.160 |
Why?
|
| Eye Injuries | 1 | 2020 | 15 | 0.160 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2020 | 19 | 0.160 |
Why?
|
| Cornea | 1 | 2020 | 55 | 0.160 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 57 | 0.160 |
Why?
|
| Equipment Failure | 1 | 2020 | 118 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2021 | 10164 | 0.150 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 192 | 0.150 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 291 | 0.140 |
Why?
|
| Prospective Studies | 3 | 2021 | 4560 | 0.140 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 88 | 0.140 |
Why?
|
| Fibrosis | 1 | 2018 | 230 | 0.130 |
Why?
|
| Veterans Health | 1 | 2017 | 19 | 0.130 |
Why?
|
| Biomedical Technology | 1 | 2017 | 26 | 0.120 |
Why?
|
| Eye Diseases | 1 | 2017 | 58 | 0.120 |
Why?
|
| Ocular Hypertension | 3 | 2020 | 9 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2018 | 315 | 0.120 |
Why?
|
| Carica | 1 | 2015 | 1 | 0.110 |
Why?
|
| Chromosomes, Plant | 1 | 2015 | 39 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 873 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2015 | 260 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 151 | 0.100 |
Why?
|
| Child, Preschool | 1 | 2020 | 3829 | 0.100 |
Why?
|
| Humans | 10 | 2021 | 93515 | 0.100 |
Why?
|
| Haplotypes | 1 | 2015 | 647 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1546 | 0.090 |
Why?
|
| Male | 8 | 2020 | 44557 | 0.080 |
Why?
|
| Risk Factors | 1 | 2020 | 5899 | 0.080 |
Why?
|
| Child | 1 | 2020 | 7355 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2021 | 9099 | 0.070 |
Why?
|
| Adult | 5 | 2020 | 27918 | 0.070 |
Why?
|
| Adolescent | 1 | 2020 | 9606 | 0.070 |
Why?
|
| Aged | 6 | 2020 | 20434 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2585 | 0.060 |
Why?
|
| Referral and Consultation | 2 | 2019 | 375 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 1922 | 0.060 |
Why?
|
| Middle Aged | 6 | 2020 | 27573 | 0.060 |
Why?
|
| Heart Failure | 1 | 2015 | 1386 | 0.060 |
Why?
|
| Female | 7 | 2020 | 48702 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2715 | 0.050 |
Why?
|
| Tonometry, Ocular | 1 | 2020 | 11 | 0.040 |
Why?
|
| Exudates and Transudates | 1 | 2020 | 13 | 0.040 |
Why?
|
| Slit Lamp Microscopy | 1 | 2020 | 4 | 0.040 |
Why?
|
| Intravitreal Injections | 1 | 2020 | 83 | 0.040 |
Why?
|
| Visual Fields | 1 | 2020 | 100 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2020 | 62 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 7061 | 0.040 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2019 | 24 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 398 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2018 | 43 | 0.040 |
Why?
|
| Ouabain | 1 | 2018 | 24 | 0.040 |
Why?
|
| Physical Examination | 1 | 2019 | 144 | 0.040 |
Why?
|
| Veterans | 1 | 2019 | 99 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 200 | 0.030 |
Why?
|
| Georgia | 1 | 2017 | 37 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 588 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 34 | 0.030 |
Why?
|
| Health Services | 1 | 2017 | 56 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 579 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1133 | 0.030 |
Why?
|
| Genes, Plant | 1 | 2015 | 96 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 2464 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 484 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2015 | 613 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2015 | 438 | 0.020 |
Why?
|
| Mice | 2 | 2018 | 12269 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 481 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 1052 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1524 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2015 | 439 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 1139 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 826 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 630 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1713 | 0.020 |
Why?
|
| Hospitalization | 1 | 2015 | 937 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2015 | 811 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 878 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1910 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 3054 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 6930 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2495 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3435 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 3502 | 0.020 |
Why?
|
| Animals | 2 | 2018 | 28155 | 0.020 |
Why?
|
| United States | 1 | 2017 | 7622 | 0.010 |
Why?
|